LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 38 of 66
Next
>>
>
926 to 950 of 1647 records
per page:

Small Molecule	barcode	cell_count	frac_dead	corpse_count	cell_count_dead	row	column	agent	concentration	role	timepoint	replicate	cell_line	dead_count	fraction_dead	cell_count__time0	dead_count__time0	cell_count__ctrl	dead_count__ctrl	fraction_dead__ctrl	increase_fraction_dead	GRvalue
Taxol	180619_MC_12	212	1.0811	244	249	10	22	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_8	493	0.6993	635.9	71.1	15071	356.7	0.0231	0.67622	-0.2138
Taxol	180619_MC_12	182	1.2080	366	296	14	15	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_9	662	0.7844	635.9	71.1	15071	356.7	0.0231	0.76129	-0.2396
Palbociclib	180619_MC_10	15595	0.0178	46	233	10	12	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_1	279	0.0176	635.9	71.1	15071	356.7	0.0231	-0.00550	1.0150
Palbociclib	180619_MC_10	13388	0.0204	64	211	11	9	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_2	275	0.0201	635.9	71.1	15071	356.7	0.0231	-0.00295	0.9488
Palbociclib	180619_MC_10	15589	0.0204	39	280	14	10	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_3	319	0.0201	635.9	71.1	15071	356.7	0.0231	-0.00302	1.0149
Palbociclib	180619_MC_11	14160	0.0246	60	290	6	19	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_4	350	0.0241	635.9	71.1	15071	356.7	0.0231	0.00105	0.9729
Palbociclib	180619_MC_11	15080	0.0213	48	274	12	14	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_5	322	0.0209	635.9	71.1	15071	356.7	0.0231	-0.00217	1.0003
Palbociclib	180619_MC_11	14226	0.0231	85	245	13	6	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_6	330	0.0227	635.9	71.1	15071	356.7	0.0231	-0.00040	0.9749
Palbociclib	180619_MC_12	16041	0.0242	115	276	8	20	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_7	391	0.0238	635.9	71.1	15071	356.7	0.0231	0.00072	1.0275
Palbociclib	180619_MC_12	16368	0.0214	75	277	12	6	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_8	352	0.0211	635.9	71.1	15071	356.7	0.0231	-0.00202	1.0365
Palbociclib	180619_MC_12	15490	0.0275	119	311	13	6	Palbociclib	0.001081167	treatment	72	2	MCF10A-GM_9	430	0.0270	635.9	71.1	15071	356.7	0.0231	0.00394	1.0120
Palbociclib	180619_MC_10	13466	0.0195	53	211	12	17	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_1	264	0.0192	635.9	71.1	15071	356.7	0.0231	-0.00385	0.9513
Palbociclib	180619_MC_10	15010	0.0207	43	269	13	8	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_2	312	0.0204	635.9	71.1	15071	356.7	0.0231	-0.00271	0.9982
Palbociclib	180619_MC_10	13856	0.0207	59	229	13	10	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_3	288	0.0204	635.9	71.1	15071	356.7	0.0231	-0.00271	0.9635
Palbociclib	180619_MC_11	15021	0.0212	64	256	6	3	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_4	320	0.0209	635.9	71.1	15071	356.7	0.0231	-0.00222	0.9985
Palbociclib	180619_MC_11	14842	0.0231	59	285	8	15	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_5	344	0.0227	635.9	71.1	15071	356.7	0.0231	-0.00042	0.9933
Palbociclib	180619_MC_11	14348	0.0219	69	247	13	7	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_6	316	0.0215	635.9	71.1	15071	356.7	0.0231	-0.00152	0.9786
Palbociclib	180619_MC_12	14973	0.0224	75	262	4	15	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_7	337	0.0220	635.9	71.1	15071	356.7	0.0231	-0.00106	0.9971
Palbociclib	180619_MC_12	15040	0.0349	186	345	7	5	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_8	531	0.0341	635.9	71.1	15071	356.7	0.0231	0.01103	0.9991
Palbociclib	180619_MC_12	15446	0.0237	94	274	8	7	Palbociclib	0.003326667	treatment	72	2	MCF10A-GM_9	368	0.0233	635.9	71.1	15071	356.7	0.0231	0.00020	1.0108
Palbociclib	180619_MC_10	11967	0.0184	47	174	5	22	Palbociclib	0.00998	treatment	72	2	MCF10A-GM_1	221	0.0181	635.9	71.1	15071	356.7	0.0231	-0.00494	0.9015
Palbociclib	180619_MC_10	13256	0.0248	69	262	6	3	Palbociclib	0.00998	treatment	72	2	MCF10A-GM_2	331	0.0244	635.9	71.1	15071	356.7	0.0231	0.00129	0.9446
Palbociclib	180619_MC_10	12731	0.0145	39	146	14	22	Palbociclib	0.00998	treatment	72	2	MCF10A-GM_3	185	0.0143	635.9	71.1	15071	356.7	0.0231	-0.00875	0.9275
Palbociclib	180619_MC_11	14254	0.0175	53	198	12	22	Palbociclib	0.00998	treatment	72	2	MCF10A-GM_4	251	0.0173	635.9	71.1	15071	356.7	0.0231	-0.00577	0.9757
Palbociclib	180619_MC_11	15356	0.0192	43	253	13	10	Palbociclib	0.00998	treatment	72	2	MCF10A-GM_5	296	0.0189	635.9	71.1	15071	356.7	0.0231	-0.00416	1.0082

|<
<<
Previous
Page 38 of 66
Next
>>
>
926 to 950 of 1647 records
per page:

HMS LINCS Project

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)